Cerebral metabolism in fatal familial insomnia: Relation to duration, neuropathology, and distribution of protease-resistant prion protein

Neurology

Volumn 49, Issue 1, 1997, Pages 126-133

  Cortelli, P ^a,c   Perani, D ^d   Parchi, P ^b   Grassi, F ^d   Montagna, P ^a   De Martin, M ^d   Castellani, R ^b   Tinuper, P ^a   Gambetti, P ^b   Lugaresi, E ^a   Fazio, F ^d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Clinica Neurologica   (Italy)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PRION PROTEIN; PROTEINASE;

AGED; ARTICLE; BRAIN METABOLISM; BRAIN SCINTISCANNING; CLINICAL ARTICLE; CODON; FAMILIAL DISEASE; GENE MUTATION; GLUCOSE UTILIZATION; HUMAN; INSOMNIA; ISOTOPE LABELING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0030837960     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.1.126     Document Type: Article

References (36)

1. Lugaresi E, Medori R, Montagna P, et al. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 1986;315:997-1003.
2. Cortelli P, Parchi P, Contin M, et al. Cardiovascular dysautonomia in fatal familial insomnia. Clin Auton Res 1991;1:15-21.
3. Manetto V, Medori R, Cortelli P, et al. Fatal familial insomnia: clinical and pathological study of five new cases. Neurology 1992;42:312-319.
4. Monari L, Chen SG, Brown P, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA 1994;91:28-39.
5. Medori R, Tritschler HJ, LeBlanc A, et al. Fatal familial insomnia: a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 1992;326:444-487.
6. Tateishi J, Brown P, Kitamoto T, et al. First experimental transmission of fatal familial insomnia. Nature 1995;376:434-435.
7. Collinge J, Palmer MS, Sidle KCL, et al. Transmission of fatal familial insomnia to laboratory animals. Lancet 1995;346: 569-570.
8. Collinge J, Palmer MS, Dryden AJ. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 1991;337:1441-1442.
9. Goldfarb LG, Petersen RB, Tabaton M, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 1992; 258:806-808.
10. Parchi P, Castellani R, Cortelli P, et al. Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann Neurol 1995;38:21-29.
11. 18F]FDG PET in fatal familial insomnia: the functional effects of thalamic lesions. Neurology 1993;43:2565-2569.
12. Medori R, Montagna P, Tritschler HJ, et al. Fatal familial insomnia. A second kindred with mutation of prion protein gene at codon 178. Neurology 1992;42:669-670.
13. Montagna P, Cortelli P, Tinuper P, et al. Fatal familial insomnia. A disease that emphasizes the role of the thalamus in the regulation of sleep and vegetative functions. In: Guilleminault C, Lugaresi E, Montagna P, Gambetti P, eds. Fatal familial insomnia: inherited prion diseases, sleep, and the thalamus. New York: Raven Press, 1994:1-14.
14. 18F]fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986;27:235-238.
15. Reivich M, Alavi A, Wolf A, et al. Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for 18F-fluoro-deoxyglucose and 11C-deoxyglucose. J Cereb Blood Flow Metab 1985;5:179-192.
16. Talairach J, Tournoux P. Coplanar stereotaxic atlas of the human brain. Stuttgart: Thieme Verlag, 1988.
17. Friston KJ, Passingham RE, Nutt JC, Heather JD, Sawle GV, Frackowiak RSJ. Localisation of PET images: direct fitting of intracommisural (AC-PC) line. J Cereb Blood Flow Metab 1989;9:690-695.
18. Wang G, Volkow ND, Wolf AP, Brodie JD, Hitzemann RJ. Intersubject variability of brain glucose measurements in young normal males. J Nucl Med 1994;35:1457-1467.
19. Lugaresi E. The thalamus and insomnia. Neurology 1992; 42(suppl 6):28-33.
20. McGeer PL, Kamo H, Harrop R, et al. Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease. Neurology 1986;36:1569-1574.
21. Friedland RP, Prusiner SB, Jagust WJ, Budinger TF, Davis RL. Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18F]-2-fluorodeoxyglucose. J Comput Assist Tomogr 1984;8:978-981.
22. Goldman S, Laird A, Flament Durand J, et al. Positron emission tomography and histopathology in Creutzfeldt-Jakob disease. Neurology 1993;43:1828-1830.
23. Holthoff V, Sandmann J, Pawlik G, Schroder R, Heiss W-D. Positron emission tomography in Creutzfeldt-Jakob disease. Arch Neurol 1990;47:1035-1038.
24. Kamo H, McGeer PL, Harrop R, et al. Positron emission tomography and histopathology in Pick's disease. Neurology 1987;37:439-445.
25. Collinge J, Whittington MA, Sidle KCL, et al. Prion protein is necessary for normal synaptic function. Nature 1994;370:295-297.
26. Tobler I, Gaus SE, DeBoer T, et al. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 1996;380:639-642.
27. Prusiner SB, DeArmond SJ. Prion diseases and neurodegeneration. Annu Rev Neurosci 1994;17:311-319.
28. Forloni G, Angeretti N, Chiesa R, et al. Neurotoxicity of prion protein fragment. Nature 1993;362:543-546.
29. Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996;39:767-778.
30. Clinton J, Forsyth C, Royston MC, Roberts GW. Synaptic degeneration is the primary neuropathological feature in prion disease: a preliminary study. Neuroreport 1993;4:65-68.
31. Kitamoto T, Shin RW, Doh-ura K, et al. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol 1992;140:1285-1294.
32. Sokoloff L. The relationship between functional and energy metabolism: its use in the localization of functional activity in the nervous system. Neurosci Res Prog Bull 1981;19:159-207.
33. Baron JC, D'Antona R, Pantano P, Serdaru M, Samson Y, Bousser MG. Effects of thalamic stroke on energy metabolism of the cerebral cortex. Brain 1986;109:1243-1259.
34. Perani D, Vallar G, Cappa SF, Messa C, Fazio F. Aphasia and neglect after subcortical stroke. A clinical/cerebral perfusion correlation study. Brain 1987;110:1211-1229.
35. Perani D, Di Piero V, Lucignani G, et al. Remote effects of subcortical cerebrovascular lesions: a SPECT cerebral perfusion study. J Cereb Blood Flow Metab 1988;8:560-567.
36. Feeney DM, Baron JC. Diaschisis. Stroke 1986;17:817-830.